Cataract in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD)

Ophthalmic Genet. 2003 Mar;24(1):49-57. doi: 10.1076/opge.24.1.49.13890.

Abstract

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) is a rare metabolic disorder that can lead to acute encephalopathy, liver disease, cardiomyopathy, rhabdomyolysis, and long-term complications involving the eye and peripheral nerves. LCHADD is a peroxisome biogenesis disorder (PBD). Except for the series presented by Tyni and colleagues (Ophthalmology 1998;105:810-824), which described visually insignificant lens opacities in association with LCHADD, previous ophthalmic papers have only reported retinal complications. We report on one case with progressive asymmetrical cataract. The more mildly affected eye had a similar morphology to that previously reported and the more severely affected eye had an unusual morphology we believe is unique to LCHADD. We discuss the range of ophthalmic presentations in our cases and in the literature. The variability of the severity of ocular complications, even between eyes in one individual, makes it difficult to test the effectiveness of therapeutic options upon the ophthalmic complications.

Publication types

  • Case Reports

MeSH terms

  • 3-Hydroxyacyl CoA Dehydrogenases / deficiency*
  • 3-Hydroxyacyl CoA Dehydrogenases / genetics
  • Adolescent
  • Cataract / enzymology*
  • Cataract / pathology
  • Female
  • Fluorescein Angiography
  • Humans
  • Peroxisomal Disorders / complications
  • Peroxisomal Disorders / enzymology*
  • Peroxisomal Disorders / pathology

Substances

  • 3-Hydroxyacyl CoA Dehydrogenases